ArticleEuropean journal of public health2026
Secular trends of incidence and prevalence of Parkinsonism subtypes: a cohort study in the United Kingdom.
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To evaluate secular trends of incidence and prevalence of Parkinson's Disease (PD), Vascular Parkinsonism (VP), and Drug-induced Parkinsonism from 2007 to 2021 in the UK. We used primary care data, Clinical Practice Research Datalink GOLD, from the UK. Individuals were included if they were registered from January 2007 to December 2021 with at least one year of prior observation. Age-standardized and crude incidence and prevalence were calculated annually; age-standardized rates were stratified by sex, and crude rates by age and sex. From 2007 to 2019, the age-standardized incidence of PD decreased from 35.61 (95% confidence interval: 33.97-37.30) to 31.27 (29.27-33.37) per 100 000 person-years. The prevalence of PD increased from 0.21% (0.21%-0.22%) in 2007, peaking in 2016 at 0.23% (0.23%-0.24%). The number of VP diagnoses has increased since 2010, whereas the incidence and prevalence of DIP remained stable. Incidence and prevalence increased with age and were generally higher in males, except for DIP, which was slightly higher in females. Crude rates showed similar trends. Though Parkinson Disease incidence has declined, prevalence has risen, suggesting improved survival. VP rates have increased, possibly due to improvements in diagnostic screening. Drug-induced Parkinsonism rates remained stable. With an aging UK population, Parkinsonism subtypes pose a growing burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.